Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 383,699 |
|
|||||
| News | - | ||||||
| Day High | 1.101 | Low High |
|||||
| Day Low | 1.00 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Kronos Bio Inc | KRON | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.04 | -3.70% | 1.04 | 15:30:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.05 | 1.00 | 1.101 | 1.04 | 1.08 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,328 | 383,699 | US$ 1.05 | US$ 402,964 | - | 0.69 - 2.29 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:29:30 | 50 | US$ 1.09 | USD |
Kronos Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 61.23M | 58.32M | - | 6.29M | -112.67M | -1.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kronos Bio News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KRON Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.74 | 1.33 | 0.7379 | 1.09 | 1,727,125 | 0.30 | 40.54% |
| 1 Month | 1.03 | 1.33 | 0.69 | 0.9778204 | 722,477 | 0.01 | 0.97% |
| 3 Months | 1.24 | 1.38 | 0.69 | 1.01 | 508,948 | -0.20 | -16.13% |
| 6 Months | 1.46 | 1.5053 | 0.69 | 1.06 | 374,444 | -0.42 | -28.77% |
| 1 Year | 1.64 | 2.29 | 0.69 | 1.19 | 322,710 | -0.60 | -36.59% |
| 3 Years | 25.16 | 25.82 | 0.69 | 5.36 | 308,814 | -24.12 | -95.87% |
| 5 Years | 28.29 | 39.605 | 0.69 | 8.86 | 294,217 | -27.25 | -96.32% |
Kronos Bio Description
| Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. |
